(NASDAQ: SNY) Sanofi's forecast annual revenue growth rate of 8.12% is forecast to beat the US Drug Manufacturers - General industry's average forecast revenue growth rate of 7.29%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 9.68%.
Sanofi's revenue in 2025 is $46,131,250,000.On average, 6 Wall Street analysts forecast SNY's revenue for 2025 to be $63,559,875,544,050, with the lowest SNY revenue forecast at $58,110,971,277,782, and the highest SNY revenue forecast at $67,064,679,841,726. On average, 6 Wall Street analysts forecast SNY's revenue for 2026 to be $67,994,421,530,482, with the lowest SNY revenue forecast at $61,518,686,910,632, and the highest SNY revenue forecast at $72,588,732,331,157.
In 2027, SNY is forecast to generate $73,929,908,457,579 in revenue, with the lowest revenue forecast at $69,658,868,654,889 and the highest revenue forecast at $76,978,879,553,947.